CD274 and glioblastoma: Our study provides direct evidences for the association between TNFRSF14 upregulation and IFN-γ signaling activation in TME: IFN-γ induces a compensatory TNFRSF14 elevation in GBM cells, and it may be a more suitable target than PD-L1 for GBM immunotherapy.